摘要
Cancer immunoediting consists of three sequential phases： elimination, equilibdum, and escape. For colorectal adenoma-carcinoma sequence, the adenoma dysplastic progression may represent an equilibdum phase and the cancer stage as escape phase. Immune system eliminates transformed enterocytes by destroying them at first, sculpts them at the same time and selects the variants subsequently that are no longer recognized and insensitive to immune effectors, and finally induces immunosuppressive state within the tumor microenvironment that facilitates immune escape and tumor outgrowth. Immunosuppression and inflammation are the two crucial features of Pi （Spteen）-deficiency. Ctassic quotations, immune evidence and ctinicat observations suggest that Spleen （but not other organs） deficiency is the key pathogenesis of colorectal cancer （CRC） microenvironment. Weakness of old age, immunosuppressive cytokines from chronic inflammation, tumor-dedved immunosuppressive factors and surrendered immune cells--regulatory T cells, myeloid-derived suppressor cells and tumor associated macrophages （TAMs） constitutes CRC microenvironment of Pi-deficiency. Furthermore, excess in superficiality, such as phlegm stagnation, blood stasis and toxin accumulation are induced by chronic inflammation on the basis of asthenia in origin, an immunosuppressive state. Great masters of Chinese medicine emphasize that strengthen Pi is the chief therapeutic principle for CRC which receives good therapeutic effects. So, Pi-deficiency based syndrome is the pivotal pathogenesis of tumor microenvironment. The immunosuppressive microenvironment facilitates immune escape which play an important role in the transition from adenoma to adenocarcinoma. There are some signs that strengthen Pi based treatment has potential capacity to ameliorate tumor environment. It might be a novel starting point to explore the mechanism of strengthen Pi based therapy in the prevention and treatment of CRC through regulation of tumor environment and immunoediting.
Cancer immunoediting consists of three sequential phases： elimination, equilibdum, and escape. For colorectal adenoma-carcinoma sequence, the adenoma dysplastic progression may represent an equilibdum phase and the cancer stage as escape phase. Immune system eliminates transformed enterocytes by destroying them at first, sculpts them at the same time and selects the variants subsequently that are no longer recognized and insensitive to immune effectors, and finally induces immunosuppressive state within the tumor microenvironment that facilitates immune escape and tumor outgrowth. Immunosuppression and inflammation are the two crucial features of Pi （Spteen）-deficiency. Ctassic quotations, immune evidence and ctinicat observations suggest that Spleen （but not other organs） deficiency is the key pathogenesis of colorectal cancer （CRC） microenvironment. Weakness of old age, immunosuppressive cytokines from chronic inflammation, tumor-dedved immunosuppressive factors and surrendered immune cells--regulatory T cells, myeloid-derived suppressor cells and tumor associated macrophages （TAMs） constitutes CRC microenvironment of Pi-deficiency. Furthermore, excess in superficiality, such as phlegm stagnation, blood stasis and toxin accumulation are induced by chronic inflammation on the basis of asthenia in origin, an immunosuppressive state. Great masters of Chinese medicine emphasize that strengthen Pi is the chief therapeutic principle for CRC which receives good therapeutic effects. So, Pi-deficiency based syndrome is the pivotal pathogenesis of tumor microenvironment. The immunosuppressive microenvironment facilitates immune escape which play an important role in the transition from adenoma to adenocarcinoma. There are some signs that strengthen Pi based treatment has potential capacity to ameliorate tumor environment. It might be a novel starting point to explore the mechanism of strengthen Pi based therapy in the prevention and treatment of CRC through regulation of tumor environment and immunoediting.
基金
Supported by the National Natural Science Foundation of China(No.81273621)
Guangdong Natural Science Foundation of China(No.2014A030313323)
